相关实验视频

Updated: Jun 24, 2025

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

对于复发性/转移性无塑性甲状腺癌的有前途的治疗点

Abdelrahman Sherif Abdalla¹, Mobeen Rahman², Saad A Khan³

¹Department of Internal Medicine, AdventHealth, Sebring, Florida, USA.

Current treatment options in oncology

|June 11, 2024

概括

无塑性甲状腺癌需要及时进行基因检测,包括BRAF V600E突变和瘤突变负担 (TMB). 向疗法和免疫疗法有潜力,但临床试验对这种罕见疾病至关重要.

科学领域:

在瘤学瘤学.
遗传学遗传学是一个
免疫治疗是一种免疫疗法.

背景情况:

无塑性甲状腺癌 (ATC) 是具有侵略性的,在复发或转移的环境中构成挑战.
早期诊断和全面的分子分析对于有效的治疗策略至关重要.

研究的目的:

概述对形甲状腺癌的基本诊断和治疗方法.
突出精准医学和免疫治疗在管理ATC中的作用.

主要方法:

通过免疫组织化学进行初始BRAF V600E测试.
针对NTRK,RET,ALK和瘤突变负担 (TMB) 的综合基因组分析.

主要成果:

美国食品和药物管理局批准的治疗方法包括dabrafenib和trametinib用于BRAF突变.
布罗利祖马布可能有利于高TMB的患者.
免疫疗法显示报告的活性,但缺乏FDA对ATC的批准.

结论:

治疗决策取决于突变特征,急迫性和患者因素.
准确药物的非标签使用是昂贵的.
对于这种孤儿疾病,迫切需要对基因组驱动和基于免疫的疗法进行进一步的临床试验.

关键词:

在ATC中,ATC是ATC.这是一种ATC基因突变.无塑性甲状腺癌是一种无塑性甲状腺癌.瘤性驱动因素瘤性驱动因素精确瘤学是一门精确的专业.精通的DNA不匹配修复技术经常发生的ATC.有针对性的治疗.瘤微环境是一个微环境.

更多相关视频

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Published on: June 2, 2023

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

Transducer Mechanism: Enzyme-Linked Receptors

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.